283 related articles for article (PubMed ID: 32468435)
21. Protective effects of paclitaxel on thioacetamide-induced liver fibrosis in a rat model.
Sharawy MH; El-Awady MS; Makled MN
J Biochem Mol Toxicol; 2021 May; 35(5):e22745. PubMed ID: 33749060
[TBL] [Abstract][Full Text] [Related]
22. Anti-fibrotic effects of Cuscuta chinensis with in vitro hepatic stellate cells and a thioacetamide-induced experimental rat model.
Kim JS; Koppula S; Yum MJ; Shin GM; Chae YJ; Hong SM; Lee JD; Song M
Pharm Biol; 2017 Dec; 55(1):1909-1919. PubMed ID: 28651481
[TBL] [Abstract][Full Text] [Related]
23. Nicotinic acid prevents experimental liver fibrosis by attenuating the prooxidant process.
Arauz J; Rivera-Espinoza Y; Shibayama M; Favari L; Flores-Beltrán RE; Muriel P
Int Immunopharmacol; 2015 Sep; 28(1):244-51. PubMed ID: 26093271
[TBL] [Abstract][Full Text] [Related]
24. Bacterial protease alleviate chronic liver fibrosis induced by thioacetamide through suppression of hepatic stellate cells consequently decrease its proliferative index.
Salem GEM; Azzam SM; Nasser MAF; El Malah T; Abd El-Latief HM; Khan RH; Chavanich S; Anwar HM
Int J Biol Macromol; 2023 Jun; 239():124243. PubMed ID: 37011746
[TBL] [Abstract][Full Text] [Related]
25. Celecoxib attenuates hepatocyte apoptosis by inhibiting endoplasmic reticulum stress in thioacetamide-induced cirrhotic rats.
Su W; Tai Y; Tang SH; Ye YT; Zhao C; Gao JH; Tuo BG; Tang CW
World J Gastroenterol; 2020 Jul; 26(28):4094-4107. PubMed ID: 32821072
[TBL] [Abstract][Full Text] [Related]
26. Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression.
Shaker ME; Salem HA; Shiha GE; Ibrahim TM
Fundam Clin Pharmacol; 2011 Apr; 25(2):248-57. PubMed ID: 20408881
[TBL] [Abstract][Full Text] [Related]
27. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation.
Wang X; Fu T; Wang J; Wang C; Liu K; Wu J; Sun H; Ma X; Sun P; Meng Q
Int Immunopharmacol; 2019 Oct; 75():105833. PubMed ID: 31450152
[TBL] [Abstract][Full Text] [Related]
28. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model.
Jang YO; Kim MY; Cho MY; Baik SK; Cho YZ; Kwon SO
BMC Gastroenterol; 2014 Nov; 14():198. PubMed ID: 25425284
[TBL] [Abstract][Full Text] [Related]
29. Preventive effects of Ophiocordyceps sinensis mycelium on the liver fibrosis induced by thioacetamide.
Wu YS; Tseng JK; Chou CH; Chiu CH; Lin YL; Chen YC
Environ Toxicol; 2017 Jun; 32(6):1792-1800. PubMed ID: 28181416
[TBL] [Abstract][Full Text] [Related]
30. Maltol Mitigates Thioacetamide-induced Liver Fibrosis through TGF-β1-mediated Activation of PI3K/Akt Signaling Pathway.
Mi XJ; Hou JG; Jiang S; Liu Z; Tang S; Liu XX; Wang YP; Chen C; Wang Z; Li W
J Agric Food Chem; 2019 Feb; 67(5):1392-1401. PubMed ID: 30644744
[TBL] [Abstract][Full Text] [Related]
31. Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation.
Liu YW; Chiu YT; Fu SL; Huang YT
J Biomed Sci; 2015 Aug; 22(1):63. PubMed ID: 26231226
[TBL] [Abstract][Full Text] [Related]
32. Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression.
Eraky SM; El-Mesery M; El-Karef A; Eissa LA; El-Gayar AM
Biomed Pharmacother; 2018 May; 101():49-57. PubMed ID: 29477472
[TBL] [Abstract][Full Text] [Related]
33. Tyrosol retards induction of fibrosis in rats.
Kutlu T; Özkan H; Güvenç M
J Food Biochem; 2021 Nov; 45(11):e13965. PubMed ID: 34636053
[TBL] [Abstract][Full Text] [Related]
34. Hepatoprotective effects of Ger-Gen-Chyn-Lian-Tang in thioacetamide-induced fibrosis in mice.
Chang ZY; Lee TY; Huang TH; Wen CK; Chien RN; Chang HH
J Chin Med Assoc; 2014 Jul; 77(7):360-6. PubMed ID: 24929999
[TBL] [Abstract][Full Text] [Related]
35. Naringin attenuates thioacetamide-induced liver fibrosis in rats through modulation of the PI3K/Akt pathway.
El-Mihi KA; Kenawy HI; El-Karef A; Elsherbiny NM; Eissa LA
Life Sci; 2017 Oct; 187():50-57. PubMed ID: 28830755
[TBL] [Abstract][Full Text] [Related]
36. Fisetin alleviates thioacetamide-induced hepatic fibrosis in rats by inhibiting Wnt/β-catenin signaling pathway.
El-Fadaly AA; Afifi NA; El-Eraky W; Salama A; Abdelhameed MF; El-Rahman SSA; Ramadan A
Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):355-366. PubMed ID: 35255766
[TBL] [Abstract][Full Text] [Related]
37. Hepatoprotective activity of a phytotherapeutic formula on thioacetamide--induced liver fibrosis model.
Kantah MK; Kobayashi R; Sollano J; Naito Y; Solimene U; Jains S; Catanzaro R; Minelli E; Polimeni A; Marotta F
Acta Biomed; 2011 Apr; 82(1):82-9. PubMed ID: 22069962
[TBL] [Abstract][Full Text] [Related]
38. Polaprezinc prevents ongoing thioacetamide-induced liver fibrosis in rats.
Kono T; Asama T; Chisato N; Ebisawa Y; Okayama T; Imai K; Karasaki H; Furukawa H; Yoneda M
Life Sci; 2012 Jan; 90(3-4):122-30. PubMed ID: 22100444
[TBL] [Abstract][Full Text] [Related]
39. Modulatory effects of curcumin, silybin-phytosome and alpha-R-lipoic acid against thioacetamide-induced liver cirrhosis in rats.
Ali SO; Darwish HA; Ismail NA
Chem Biol Interact; 2014 Jun; 216():26-33. PubMed ID: 24704557
[TBL] [Abstract][Full Text] [Related]
40. Detrimental effects of nicotine on thioacetamide-induced liver injury in mice.
Zhou Z; Park S; Kim JW; Zhao J; Lee MY; Choi KC; Lim CW; Kim B
Toxicol Mech Methods; 2017 Sep; 27(7):501-510. PubMed ID: 28440100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
